Mutai, Hideki
Kuroda, Yukiko
Noji, Shinobu
Ichikawa, Saki
Matsuo, Koichi
Tanaka, Satoshi
Kataoka, Naoyuki
Fujioka, Masato
Matsunaga, Tatsuo
Funding for this research was provided by:
Japan Society of Promotion of Sciences (18K0933)
Japan Society of Promotion of Sciences Platform for Advanced Genome Science (212118)
Amgen Foundation (Undergraduate Summer Research Program in Science and Biotechnology 2022)
Uehara Memorial Foundation (201820479)
Article History
Received: 2 February 2025
Accepted: 23 April 2025
First Online: 28 April 2025
Change Date: 11 July 2025
Change Type: Update
Change Details: The original online version of this Article was revised: The original version of this Article contained an error in the Acknowledgements section. It now reads: “The authors thank Dr. Atsuo Ogura at Bioresource Engineering, RIKEN, for help with in vitro fertilization of <i>Slc12a2</i><sup><i>Em1</i></sup> mice; Dr. Atsushi Toyoda at Comparative Genomics Laboratory, National Institute of Genetics, for technical support with RNA-seq; and Dr. Mikio Furuse of the National Institute for Physiological Sciences for providing rabbit anti-Claudin 9 antiserum. This study was supported by grants to HM from the Japan Society of Promotion of Sciences (KAKENHI; grant numbers 18K0933, 21K09598, and 24K12688), and from the JSPS Platform for Advanced Genome Science (grant number 212118), by a grant to TM from the Uehara Memorial Foundation (grant number 201820479), and by a grant to SI from the Amgen Foundation (Undergraduate Summer Research Program in Science and Biotechnology 2022).”
Declarations
:
: The authors declare no competing interests.
: All experimental protocols were approved by Institutional Animal Care and Use Committee of NHO Tokyo Medical Center (23-animal-01, 18-animal-02). All experiments were performed in accordance with relevant guidelines and regulations. Authors complied with the ARRIVE guidelines ().